This inventor holds 1 USPTO granted patent. Top assignee: Rigel Pharmaceuticals, Incorporated. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Xiulan Xz Zhou: Innovator in Leukocyte Activation Modulation
Introduction
Xiulan Xz Zhou is a prominent inventor based in Palo Alto, CA (US). He has made significant contributions to the field of immunology, particularly in the modulation of leukocyte activation. His innovative work has the potential to impact the treatment of various disorders related to immune system dysfunction.
Latest Patents
Xiulan Xz Zhou holds a patent titled "Modulators of leukocyte activation, compositions and methods of use." This invention provides compositions and methods for modulating leukocyte activation. It includes nucleic acids encoding proteins that can modulate leukocyte activation, as well as methods for treating disorders related to leukocyte dysfunction. The patent also covers prophylactics for the prevention of such disorders and diagnostic methods for determining these conditions. Furthermore, it includes assays for identifying bioactive agents capable of modulating leukocyte activation. He has 1 patent to his name.
Career Highlights
Xiulan Xz Zhou is currently associated with Rigel Pharmaceuticals, Incorporated, where he continues to advance his research in immunology. His work at Rigel Pharmaceuticals has allowed him to collaborate with other talented professionals in the field.
Collaborations
Some of his notable coworkers include Brian Wong and Chong Alan Fu. Their collective expertise contributes to the innovative environment at Rigel Pharmaceuticals.
Conclusion
Xiulan Xz Zhou's contributions to the field of leukocyte activation modulation highlight his role as a key innovator in immunology. His patent and ongoing work have the potential to lead to significant advancements in the treatment of immune-related disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
